Edition:
United Kingdom

Helius Medical Technologies Inc (HSM.TO)

HSM.TO on Toronto Stock Exchange

13.20CAD
17 Aug 2018
Change (% chg)

$0.30 (+2.33%)
Prev Close
$12.90
Open
$12.84
Day's High
$13.20
Day's Low
$12.84
Volume
4,395
Avg. Vol
16,954
52-wk High
$25.45
52-wk Low
$9.00

Latest Key Developments (Source: Significant Developments)

Helius Medical Technologies provides clarification on clinical trial results
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Helius Medical Technologies Inc :Helius Medical Technologies provides clarification on clinical trial results and confirms intention to include traumatic brain injury (TBI) registrational and long-term treatment trial data to support application for clearance by the FDA.  Full Article

Helius Medical Technologies announces positive results from its registrational clinical trial for traumatic brain injury
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Helius Medical Technologies Inc :Helius Medical Technologies announces positive results from its registrational clinical trial for traumatic brain injury (TBI).  Full Article

BRIEF-Helius Medical - If Co Fails To Ensure Commercialization Of Pons Treatment Is Available For U.S. Government By Dec. 31, 2021, Co May Forfeit Right To Pursue Commercialization

* HELIUS MEDICAL TECHNOLOGIES - IF CO FAILS TO ENSURE COMMERCIALIZATION OF PONS TREATMENT IS AVAILABLE FOR U.S. GOVERNMENT BY DEC. 31, 2021, CO MAY FORFEIT RIGHT TO PURSUE COMMERCIALIZATION

No consensus analysis data available.